Physician profile
Brian P Biernat
NPI 1386629640
$784.39
in general payments reported to CMS, 2019-2025
17 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $51.03 · 2022: $27.36 · 2023: $79.89 · 2024: $255 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $150.23 | 2019-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $121.36 | 2024 | |
| Leo Pharma INC. | $99.54 | 2024-2025 | Adbry, Anzupgo |
| Incyte Corporation | $59.30 | 2025 | Opzelura |
| Janssen Biotech, INC. | $50.02 | 2019-2025 | Tremfya |
| Abbvie INC. | $46.90 | 2019-2022 | |
| Genentech USA, INC. | $46.57 | 2019-2020 | |
| Ucb, INC. | $36.70 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $33.80 | 2023 | |
| Galderma Laboratories, L.P. | $25.21 | 2019-2023 | |
| Epi Health, LLC | $20.74 | 2020 | |
| Aclaris Therapeutics, INC. | $20.27 | 2019 | |
| Lilly USA, LLC | $18.15 | 2024 | Taltz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.68 | 2024 | Cyltezo |
| Dermavant Sciences, INC. | $14.43 | 2024 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $13.58 | 2019 | |
| Almirall LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Biernat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.